Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Matritech (NASDAQ - NMPS) -- Ignore unavailable to you. Want to Upgrade?

To: Wesley0428 who wrote (575)	2/19/1998 6:11:00 PM
From: John McCarthy	Respond to of 849

Wesley - I'm not arguing - but be advised. There is revenue to fill a distribution channel, and there is real revenue i.e. to end user. The next 2 qtrs. revenue, based on this new distributor thingie (which I still don't get) will be to fill their distribution pipeline, after that .... its all based on the run rate that the product is selling to the end user. i.e. from the channel to the end user. I do want this NMPS guy to understand this. Because I think he is stupid and arrogant enough to think that we don't understand it. Lastly, in the real world the presentation of Balance Sheet columns usually follows the order that P&L columns are presented in. e.g. if the P&L is presented March 97 vs March 96 then the balance sheet columns might flow (depending on the time periods) March 97 December 96 It is done this way as a courtesey(sp?) to the reader. i.e. one less thing to read (column headings) Thanks again for your information and insight. Regards, John P.S. Two of our current dist. guys are UCOR and LAB One (?) I sure hope we ain't losing UCOR. They do about 2,400 urologists a year.